Weifang Yaxing Chemical Co., Ltd. (SHA:600319)
China · Delayed Price · Currency is CNY 5.83
+0.03 (0.52%)
Nov 13, 2026, 11:29 AM CST
Weifang Yaxing Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 857.75 | 834.99 | 889.63 | 820.43 | 841.58 | 191.57 |
Other Revenue | 25.17 | 25.17 | 20.78 | 4.42 | 5.07 | 1.14 |
| 882.91 | 860.16 | 910.42 | 824.85 | 846.65 | 192.7 | |
Revenue Growth | -1.21% | -5.52% | 10.37% | -2.57% | 339.36% | 290.93% |
Cost of Revenue | 860.87 | 876.85 | 900.74 | 809.71 | 725.32 | 193.66 |
Gross Profit | 22.04 | -16.69 | 9.68 | 15.14 | 121.33 | -0.96 |
Selling, General & Admin | 73.53 | 71.1 | 67.18 | 65.3 | 56.31 | 49.87 |
Research & Development | 11.66 | 10.36 | 9.67 | 8.6 | 8.32 | 5 |
Other Operating Expenses | 7.98 | 7.84 | 7.74 | 6.84 | 2.7 | 5.26 |
Operating Expenses | 93.29 | 88.59 | 89.42 | 81.97 | 67.69 | 57.29 |
Operating Income | -71.25 | -105.28 | -79.75 | -66.83 | 53.64 | -58.25 |
Interest Expense | -90.31 | -80.54 | -66.11 | -51.44 | -46.79 | -53.77 |
Interest & Investment Income | 0.87 | 0.81 | 0.42 | 2.86 | 2.42 | 4.26 |
Currency Exchange Gain (Loss) | -0.41 | -0.41 | -1.94 | -1.03 | 0.14 | -0.01 |
Other Non Operating Income (Expenses) | -4.69 | -6.91 | -7.08 | 5.49 | 15.9 | 287.87 |
EBT Excluding Unusual Items | -165.8 | -192.33 | -154.45 | -110.95 | 25.31 | 180.1 |
Gain (Loss) on Sale of Investments | 1.22 | - | -2.4 | - | -0.1 | - |
Gain (Loss) on Sale of Assets | 8.38 | -0.22 | 0.03 | 0.11 | 93.45 | 0.09 |
Asset Writedown | -8.89 | -12.35 | -2.35 | - | - | - |
Other Unusual Items | 48.61 | 48.37 | 60.85 | 117.52 | 0.45 | 12.86 |
Pretax Income | -116.48 | -156.53 | -98.33 | 6.68 | 119.11 | 193.05 |
Income Tax Expense | 0.44 | 0.41 | 0.42 | 0.41 | 10.27 | 0.02 |
Earnings From Continuing Operations | -116.92 | -156.94 | -98.75 | 6.28 | 108.84 | 193.03 |
Minority Interest in Earnings | 1.07 | 0.76 | 1.72 | 0.09 | - | - |
Net Income | -115.85 | -156.18 | -97.03 | 6.36 | 108.84 | 193.03 |
Net Income to Common | -115.85 | -156.18 | -97.03 | 6.36 | 108.84 | 193.03 |
Net Income Growth | - | - | - | -94.15% | -43.61% | - |
Shares Outstanding (Basic) | 386 | 390 | 388 | 318 | 351 | 316 |
Shares Outstanding (Diluted) | 386 | 390 | 388 | 318 | 351 | 316 |
Shares Change | 0.39% | 0.59% | 21.97% | -9.37% | 10.96% | -1.40% |
EPS (Basic) | -0.30 | -0.40 | -0.25 | 0.02 | 0.31 | 0.61 |
EPS (Diluted) | -0.30 | -0.40 | -0.25 | 0.02 | 0.31 | 0.61 |
EPS Growth | - | - | - | -93.55% | -49.18% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -275.14 | -443.22 | -49.89 | -416.28 | -0.29 | -306.17 |
Free Cash Flow Per Share | -0.71 | -1.14 | -0.13 | -1.31 | -0.00 | -0.97 |
Gross Margin | 2.50% | -1.94% | 1.06% | 1.84% | 14.33% | -0.50% |
Operating Margin | -8.07% | -12.24% | -8.76% | -8.10% | 6.34% | -30.23% |
Profit Margin | -13.12% | -18.16% | -10.66% | 0.77% | 12.86% | 100.17% |
Free Cash Flow Margin | -31.16% | -51.53% | -5.48% | -50.47% | -0.03% | -158.88% |
EBITDA | 15.1 | -20.44 | 3.09 | -2.64 | 106.03 | -36.59 |
EBITDA Margin | 1.71% | -2.38% | 0.34% | -0.32% | 12.52% | -18.99% |
D&A For EBITDA | 86.35 | 84.84 | 82.84 | 64.19 | 52.39 | 21.67 |
EBIT | -71.25 | -105.28 | -79.75 | -66.83 | 53.64 | -58.25 |
EBIT Margin | -8.07% | -12.24% | -8.76% | -8.10% | 6.33% | -30.23% |
Effective Tax Rate | - | - | - | 6.08% | 8.62% | 0.01% |
Revenue as Reported | 882.91 | 860.16 | 910.42 | 824.85 | 846.65 | 192.7 |